EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals
EyePoint described its Phase 3 wet AMD trials as designed in close alignment with the FDA. LUCIA then missed its primary endpoint, and LUGANO's favorable result depended on excluding nine DURAVYU patients. NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Shares of EyePoint Pharmaceuticals (NASDAQ:...
Covered in this story
What has happened since
- Advanced Micro Devices is down 5.0% since this was published, 2 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $EYPT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Eyepoint Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.